AGM
Federal Agricultural Mortgage Corporation
AGM has a slight edge over BAC overall, supported by stronger valuation.
BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
AGM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
AGM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AGM.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
AGM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8x | $175 | — |
| Cheap | 9x | $169 | -3.4% |
| Current | 9.3x | $175 | — |
| Fair | 11x | $198 | +13% |
| Expensive | 12x | $230 | +31% |
Historical ranges are pointers, not guarantees.
AGM's PE is in its cheap range at 9.3x. If earnings grow as analysts expect, today's price would be 8.0x next year's earnings.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over AGM in the historical PE scenario, which offers more potential upside but is not a forecast.
AGM Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for AGM, with profitability improving.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
AGM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $21.78 | +15% |
| Q3 2026 | $18.88 | +7.6% |
| Q2 2026 | $18.29 | +7.8% |
| Q1 2026 | $17.36 | +7.4% |
| Q4 2025 | $16.62 | +1.1% |
| Q3 2025 | $17.55 | +13% |
| Q2 2025 | $16.97 | +3.6% |
| Q1 2025 | $16.17 | -1.4% |
| Q4 2024 | $16.44 | +4% |
AGM earned $18.88 per share over the past year, up 7.6% from the year before.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over AGM on earnings, with more consistent year-over-year improvement.
AGM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $125.3M | +20% |
| Q2 2026 | $125M | +22% |
| Q1 2026 | $109.1M | +16% |
| Q4 2025 | $107.5M | +6.1% |
| Q3 2025 | $104M | +15% |
| Q2 2025 | $102.6M | +14% |
| Q1 2025 | $94.3M | +0.7% |
| Q4 2024 | $101.3M | +19% |
AGM has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 64% | -0.6 points |
| Q2 2026 | 65% | +1.7 points |
| Q1 2026 | 65% | -1.5 points |
| Q4 2025 | 56% | -11 points |
| Q3 2025 | 64% | -4.7 points |
| Q2 2025 | 64% | -2.2 points |
| Q1 2025 | 67% | -5.9 points |
| Q4 2024 | 68% | -3.6 points |
AGM has the edge over BAC on profitability, with a higher operating margin.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
AGM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $362.7M | +389% |
| Q2 2026 | $40.4M | +$88.1M |
| Q1 2026 | $92.1M | +$141.9M |
| Q4 2025 | $103.4M | -72% |
| Q3 2025 | $74.2M | +$118.6M |
| Q2 2025 | -$47.7M | -191% |
| Q1 2025 | -$49.8M | -122% |
| Q4 2024 | $367.5M | +$534.4M |
AGM has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
AGM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +27K shares |
| 1 year | -0.6% | -63K shares |
| 3 years | -0.3% | -29K shares |
| 5 years | +0.6% | +67K shares |
| Available history | +1.2% | +131K shares |
AGM has 11M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $7.1M |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over AGM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
AGM Net Leverage
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
AGM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.8 | Neutral |
| Stochastic | 8.2 | Oversold |
AGM's weekly RSI is 35 (neutral) and its Stochastic is 8 (oversold).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
AGM PE vs Financial Services Sector
| Metric | AGM | Sector median | Relative |
|---|---|---|---|
| PE | 9.3x | 13x | 29% below |
| PE % | 23 | 63 | 40 pts below |
AGM has the edge over BAC on valuation relative to its sector.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
AGM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $199.2 | 12% below |
| 20 week MA | $211.2 | 17% below |
| 50 week MA | $186.6 | 6.1% below |
| 100 week MA | $185.7 | 5.6% below |
| 200 week MA | $177.6 | 1.3% below |
AGM is in a downtrend: it's below all five of its weekly moving averages, and 1.3% below its 200-week average.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over AGM on trend strength, trading above more of its moving averages.
AGM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $84.2 | $73.9 | -12% |
| 2021 | $73.9 | $120.7 | +63% |
| 2022 | $120.7 | $114.0 | -5.5% |
| 2023 | $114.0 | $191.2 | +68% |
| 2024 | $191.2 | $197.3 | +3.2% |
| 2025 | $197.3 | $177.6 | -10% |
| 2026 YTD | $177.6 | $175.2 | -1.3% |
AGM has the edge over BAC on returns for 2026, with the stronger performance.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.